Your browser doesn't support javascript.
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply.
Alexander, James L; Kennedy, Nicholas A; Lees, Charlie W; Ahmad, Tariq; Powell, Nick.
  • Alexander JL; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
  • Kennedy NA; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Lees CW; Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK; Department of Gastroenterology, Western General Hospital, Edinburgh, UK.
  • Ahmad T; Department of Gastroenterology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
  • Powell N; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: nicholas.powell@imperial.ac.uk.
Lancet Gastroenterol Hepatol ; 6(7): 523-524, 2021 07.
Article in English | MEDLINE | ID: covidwho-1263403

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Gastroenterology / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2021 Document Type: Article Affiliation country: S2468-1253(21)00194-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Gastroenterology / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2021 Document Type: Article Affiliation country: S2468-1253(21)00194-1